Shelf Registation Filing, Aastrom Biosciences (ASTM)
ASTM is down 3.3% to $4.06 as it plans to sell as much as $75M in securities.
It was expected, by many based on the costs of the up-coming CLI trial … more to follow!
Categories: NASDAQ: ASTM, Shelf Filing up to $75M, Stem Cell Technology







